Background: Mitochondrial dysfunction is well documented in OA and has the capacity to promote abnormalities in chondrocyte function and viability contributing to cartilage degeneration. Previous studies have showed the mtDNA haplogroup J are associated with incidence and progression of OA. Cybrids are optimal cellular models to study the real mitochondrial biology and function implications in the cellular behaviour, since they carry different mitochondrial variants with the same nuclear background, therefore, excluding the variations because of nuclear genome. Objectives: The aim of this work is to test the real role of mtDNA in cellular activity, using cybrids with mtDNA from healthy donors (without OA) and from patients with knee OA. Methods: Cybrids were developed using 143B.TK -Rho-0 cell line (nuclear donor) and platelets (mitochondrial donors) from healthy (without AO-N-) and knee OA donors. The OXPHOS function was evaluated by SeaHorse XFp after addition of oligomycin, FCCP and Rotenone/Antimycin A. The metabolic status was evaluated by glucose consumption and lactic acid production. The glycolytic activity was measure after addition of glucose, oligomycin and 2-dioxyglucose using Seahorse XFp. Appropriate statistical analyses were performed with GraphPad Prism v6. Results: OA cybrids had lower basal respiration (92.07±39.9 and 155.5±54.08, p<0.0005), and maximal respiratory capacity (114.7±50.1 and 160.6±44.7, p<0.05) than N. The analysis of ATP production was lower in OA than in N cybrids (66.69±28.69 versus 101.5±42.04 p≤0.05). The % spare respiratory capacity value for the N was significantly lower than in OA cybrids (107±16.21 versus 124.7±5.97, p≤0.0005). Cybrids carrying the mtDNA from OA patients showed higher glucose consumption than N cybrids (43.77±8.87 mg/ml and 31.91±13.69 mg/ml; p<0.05) however in the lactic acid production did not exit differences. The glycolytic activity was evaluated and showed that OA cybrids had lower glycolysis (71.05±4.83 versus 85.43±11.18, p<0.05) but higher glycolytic reserve than N cybrids (56.60±7.5 versus 39.73±19.13, p≤0.05). Conclusions: Cybrids have different metabolic behaviour, being N more efficient using glucose via glycolysis. We found differences statistical significate in the parameters that describe the mitochondrial respiration capacity, in this line OA cybrids had lower mitochondrial respiration and produce less ATP than the cybrids obtained from healthy patients. These results showed that the mitochondria obtained from healthy and OA donors had a different behaviour. These data also offer a real rationale for why mitochondria alterations play an important role in the incidence of OA.
Background: Ankylosing spondylitis (AS) is a chronic inflammatory disease, which is difficult to diagnose in the early stages. Increasing evidences have shown that MicroRNAs (miRNAs) may serve as novel biomarkers for AS. Exosome can function as vehicles to deliver miRNAs in body fluids including saliva and plasma. However, the relationship between exosome-delivered miRNAs and AS has yet to be determined. Objectives: The aim of this study is to detect the altered miRNAs profiles of plasma-derived exosome in AS patients by small RNA-Seq Analysis. Methods: Ribo TM kit was used to isolate exosome. Small RNA Sample Pre Kit was used to build libraries in 3 AS patients and 3 healthy volunteers (HV), following by IlluminaHiSeq platform sequencing and bioinformatics analysis. Quantitative reverse-transcription PCR (qRT-PCR) was used to confirm the expression of the highly-expressed miRNA in another 10 AS patients and 10 HV, and receiveroperator characteristic (ROC) curve was used to evaluate the diagnostic value of miRNAs. Results: Small RNA-Seq analysis showed that the Q30 value of HV and AS patients were higher than 95% (Fig.1-A) . The amount of miRNA in HV and AS patients were (509.667±77.501) and (632.000±43.555). 80 up-regulated and 19 down-regulated exosomal miRNAs were identified in AS patients, compared with HV (|log2Ratio|>1, P <0.05) (Fig.1-B-C) . The target genes of the 34 highly-expressed miRNAs from the 99 differently-expressed miRNAs were 7869, and the main function of these target genes are involved in the regulation of endocytosis and protein modification process analyzed by GO and KEGG. The qRT-PCR results indicated that the expression level of miRNA21-5P and miRNA423-5P in AS patients were (2.940±1.572) and (2.520±1.401) times higher than that of HV (Fig.1-D-E) . ROC curve analysis showed that miRNA21-5P and miRNA423-5P had significant diagnostic value for AS with the AUC of 0.890 (CI95%: 0.723-1.057) and 0.835 (CI95%: 0.621-1.039) respectively (Fig.1-F) .
Conclusions:
The miRNAs profiles in plasma-derived exosome of AS patients are significant different from HV. miRNA21-5P and miRNA423-5P are higher expressed in AS patients. Thus, plasma-derived exosomal miRNAs might be reliable biomarkers to identify AS. 
